Neurology · Gordon Holmes Syndrome

Long-Term Care and Daily Life

At a Glance

Long-term care for Gordon Holmes syndrome is individualized and coordinated across neurology, endocrinology, rehabilitation, and other specialties. Monitoring bone density, hormone treatment, swallowing, vision, mood, and thinking—along with fall prevention—helps preserve safety and independence.

Living with Gordon Holmes Syndrome (GHS) requires moving from the “diagnostic phase” into a “management phase.” Because GHS affects multiple body systems, your long-term care is not about a single doctor, but a coordinated team that monitors your health from different angles ^[1]^[2].

Your Multidisciplinary Care Team

A “medical home” for GHS usually involves several specialists who should ideally communicate with each other ^[2]:

Neurologist: Oversees movement, coordination, and potential seizures (especially in STUB1 variants) ^[1].
Endocrinologist: Manages hormone replacement and monitors bone health ^[3].
Rehabilitation Team: Includes Physical Therapy (PT) for balance, Occupational Therapy (OT) for daily tasks, and Speech-Language Pathology (SLP) for speech and swallowing safety ^[4].
Ophthalmologist: Often recommended based on gene and findings (e.g., PNPLA6) to monitor for retinal changes ^[5]^[6].
Neuropsychologist: Can help monitor changes in memory, thinking, or mood, which are common in the RNF216 subtype ^[1]^[7].

Flexible Care Planning

While there is no well-established GHS-specific surveillance schedule, an individualized care-planning framework based on symptoms may look like:

Neurological & Rehab Review: Tracking changes in gait, hand dexterity, and speech ^[8]^[9]. The interval varies based on symptoms and stability ^[8].
Endocrine Check-up: Monitoring hormone levels, treatment safety, and sexual function. The interval is set by your clinician ^[3]^[10].
Safety Screenings: Routine clinical screening for “non-motor” symptoms like swallowing difficulties, sleep issues, or mood changes ^[11]^[12].

Prioritizing Bone Health

Bone health is a major long-term concern in GHS. Because the body may have lacked sex hormones during the critical bone-building years of puberty, many patients have low bone mineral density (osteopenia or osteoporosis) ^[13]^[10].

DEXA Scans: This specialized X-ray measures bone mineral density. Timing depends on baseline bone mineral density, treatment, fracture risk, and age ^[10]^[14].
Fracture Prevention: Low bone density combined with the balance issues of ataxia creates a high risk for fractures during a fall ^[15].
Nutrition and Supplements: Dietary calcium and vitamin D levels should be assessed rather than automatically supplementing ^[14].

Day-to-Day Management and Fall Prevention

Managing ataxia day-to-day focuses on maintaining function and preventing injury.

Goal-Directed Rehab: Engaging in regular balance or aerobic training can improve walking speed and coordination ^[16]^[17].
Home Safety: Simple changes like removing trip hazards, installing grab bars in the bathroom, and using high-quality lighting can significantly reduce fall risks ^[18]. Consider assistive devices like canes or wheelchairs when recommended, and review driving or workplace accommodations. Have a written plan for what to do after a fall.
Energy Conservation: Ataxia can be physically exhausting. Planning your day to include rest periods can help manage the fatigue that often makes coordination worse ^[16].

Managing GHS is a marathon, not a sprint. By building a proactive care team and sticking to a regular monitoring schedule, you can address symptoms early and focus on maintaining your independence and quality of life.

Common questions in this guide

How is long-term care for Gordon Holmes syndrome coordinated?

Long-term care usually involves a neurologist, endocrinologist, rehabilitation professionals, and other specialists as needed. These clinicians should communicate about movement symptoms, hormone replacement, bone health, swallowing, vision, mood, and thinking.

How often should I have a DEXA scan with Gordon Holmes syndrome?

There is no single schedule for everyone. The timing depends on your bone density, hormone treatment, fracture risk, and age, so your clinician should set the interval and interpret the results.

What can I do to reduce falls and stay independent?

Balance-focused rehabilitation, regular activity suited to your abilities, and rest periods can help maintain function. Removing trip hazards, adding grab bars and good lighting, and using a cane or wheelchair when advised can make daily activities safer.

Why is bone health especially important in Gordon Holmes syndrome?

Low sex hormone levels during the years when bones normally build can lead to osteopenia or osteoporosis. When low bone density occurs with balance problems, a fall is more likely to cause a fracture, so bone monitoring and fall prevention are important.

Which screenings may depend on my GHS gene change?

Screening can be individualized by the gene involved and your symptoms. Eye examinations may be important for some people, including those with PNPLA6-related findings, while cognitive or mood monitoring may be considered in RNF216-related disease and seizure monitoring may be relevant with STUB1 variants.

How can hormone replacement and bone care be monitored together?

Your endocrinologist can monitor hormone levels, treatment safety, sexual function, and bone health while coordinating with your neurologist and rehabilitation team. Ask your clinicians to agree on who orders bone-density testing and how results will affect your care.

Get notified when new evidence is published on Cerebellar ataxia-hypogonadism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Clinical and Genetic Profile of Gordon-Holmes Syndrome: A Review of Published Cases : Original Article.
Mahale RR, Mailankody P
Cerebellum (London, England) 2026; (25(3)).
PMID: 42080998
2
Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.
Bremova-Ertl T, Hofmann J, Stucki J, et al.
Cells 2023; (12(18)) doi:10.3390/cells12182314.
PMID: 37759536
3
Hypogonadotropic Hypogonadism as First Presentation of the Severe Neuroendocrine Disorder Caused by RNF216.
Rochtus A, Asscherickx W, Timmers M, et al.
JCEM case reports 2024; (2(11)):luae195 doi:10.1210/jcemcr/luae195.
PMID: 39444518
4
Neurodegenerative Cerebellar Ataxia.
Rosenthal LS
Continuum (Minneapolis, Minn.) 2022; (28(5)):1409-1434 doi:10.1212/CON.0000000000001180.
PMID: 36222772
5
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422
6
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399
7
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients.
Maas RPPWM, Killaars S, van de Warrenburg BPC, Schutter DJLG
Journal of neurology 2021; (268(9)):3456-3466 doi:10.1007/s00415-021-10516-7.
PMID: 33743045
8
Movement Disorders in Hereditary Cerebellar Ataxia.
Damásio J, Costa S, Moura J, et al.
Movement disorders clinical practice 2025; (12(6)):784-795 doi:10.1002/mdc3.14358.
PMID: 39936868
9
Functional Outcomes Associated With Independence in Walking Among People With Hereditary Ataxias: An Exploratory Cross-sectional Study.
Giangiardi VF, Perracini MR, da Silva ML, et al.
Physical therapy 2022; (102(4)) doi:10.1093/ptj/pzac006.
PMID: 35079839
10
Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L, Caerels S, Jardi F, et al.
Andrology 2019; (7(3)):302-306 doi:10.1111/andr.12604.
PMID: 30851011
11
Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease.
Mota JP, Rodrigues IT, Ferreira AF, et al.
Cerebellum (London, England) 2025; (24(6)):158 doi:10.1007/s12311-025-01911-1.
PMID: 41003838
12
Psychiatric disorders, spinocerebellar ataxia type 3 and CAG expansion.
Silva UC, Marques W, Lourenço CM, et al.
Journal of neurology 2015; (262(7)):1777-9 doi:10.1007/s00415-015-7807-3.
PMID: 26067219
13
Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism.
de Silva NL, Hyams E, Grant B, et al.
The Journal of clinical endocrinology and metabolism 2025; (111(1)):280-290 doi:10.1210/clinem/dgaf488.
PMID: 41032457
14
Bone involvement in males with Kallmann disease.
Iolascon G, Frizzi L, Bianco M, et al.
Aging clinical and experimental research 2015; (27 Suppl 1()):S31-6 doi:10.1007/s40520-015-0421-5.
PMID: 26201943
15
Boucher Neuhäuser Syndrome - A rare cause of inherited hypogonadotropic hypogonadism. A case of two adult siblings with two novel mutations in PNPLA6.
Langdahl JH, Frederiksen AL, Nguyen N, et al.
European journal of medical genetics 2017; (60(2)):105-109 doi:10.1016/j.ejmg.2016.11.003.
PMID: 27866050
16
Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.
Milne SC, Roberts M, Williams S, et al.
Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.
PMID: 39520242
17
Changes in Gait After Training for Individuals With Cerebellar Ataxia.
Smani A, Lee S, Spinner M, Barbuto S
Archives of rehabilitation research and clinical translation 2025; (7(4)):100540 doi:10.1016/j.arrct.2025.100540.
PMID: 41477095
18
Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.
Alawadhi A, Almarzooqi A, Khan M, Alrukn S
Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.
PMID: 42147656

This page is for informational purposes only and does not constitute medical advice. Your neurology, endocrinology, and rehabilitation clinicians should tailor monitoring, treatment, and safety planning to your needs.